Therapeutic vulnerability to ATR inhibition in concurrent <i>NF1</i> and <i>ATRX-</i> deficient high-grade solid tumors

Ming Yuan(Johns Hopkins University), Fausto J. Rodríguez(University Hospital of Zurich)
bioRxiv (Cold Spring Harbor Laboratory)
February 3, 2022
Cited by 3


Related Papers